Every article on this site is written by AI from official sources and checked by a second AI. How it works
Final ruleTook effect Aug. 8, 2025

Specific Listing for Dipentylone, a Currently Controlled Schedule I Substance

Built by the Tribune's code from the Federal Register. No AI wrote this page. Published in the Federal Register Aug. 8, 2025. Document 2025-15177. Updated Nov. 20, 2026.

What it does

The Drug Enforcement Administration (DEA) is establishing a specific listing and DEA Controlled Substances Code Number (drug code) for 1-(1,3-benzodioxol-5-yl)-2-(dimethylamino)pentan-1-one (dipentylone; N,N-dimethylpentylone) in schedule I of the Controlled Substances Act (CSA). Although dipentylone is not specifically listed in schedule I of the CSA with its own unique drug code, it is a schedule I controlled substances in the United States because it is a positional isomer of N-ethylpenthylone (controlled August 31, 2018), which is a schedule I hallucinogen. Therefore, DEA is simply amending the schedule I hallucinogenic substances list in its regulations to separately include dipentylone.

The Drug Enforcement Administration's summary, as published in the Federal Register.

What changed in the regulation

1 part of Title 21 of the Code of Federal Regulations:

21 CFR 1308

Wording on eCFR: the day before it took effect and from the day it took effect (first part listed).

Compared with

The Drug Enforcement Administration has published 27 final rules in 2026 so far, compared with 17 in all of 2025.

Counted by the Tribune from Federal Register records since Jan. 1, 2025.

What happens next and when

Effective August 8, 2025.

The agency's dates, word for word.

Document number2025-15177
ActionFinal rule.
AgenciesJustice Department; Drug Enforcement Administration
PublishedAug. 8, 2025
Effective dateAug. 8, 2025
DocketDEA-2025-0192

Source: the Federal Register (public domain). The document in the Federal Register